The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

Show other versions (1)

<h4>Background</h4>Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of i...

Full description

Bibliographic Details
Main Authors: Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1004155

Internet

https://doi.org/10.1371/journal.pmed.1004155

Similar Items